Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI.
The role of bone marrow transplantation (BMT) in first remission of children with high-risk acute lymphoblastic leukemia (ALL) remains unclear. There were 3676 patients (aged 1 to 15 years) entered into the United Kingdom (UK) Medical Research Council (MRC) trials UKALL X and XI from 1985 to 1997. O...
Main Authors: | Wheeler, K, Richards, S, Bailey, C, Gibson, B, Hann, I, Hill, F, Chessells, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
by: Chessells, J, et al.
Published: (2002) -
Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
by: Chessells, J, et al.
Published: (1992) -
Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
by: Wheeler, K, et al.
Published: (1998) -
Comparison of bone marrow transplantation with chemotherapy for high risk childhood acute lymphoblastic leukaemia in first remission.
by: Wheeler, K, et al.
Published: (1998) -
Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
by: Wheeler, K, et al.
Published: (1998)